業績一覧

ACHIEVEMENT LIST

  • Nakazono A, Nakamaru Y, Ramezanpour M, Kondo T, Watanabe M, Hatakeyama S, Kimura S, Honma A, Wormald PJ, Vreugde S, Suzuki M, Homma A.: Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells.

    Front Cell Infect Microbiol. 11:655666. eCollection, 2021.

  • Fukuda A, Fujiwara K, Morita S, Hoshino K, Yanagi H, Nakamaru Y, Homma A:Prognostic factors for duration of vertigo after stapes surgery via a time-to-event analysis.

    Acta Otolaryngol. 141:216-221,2021

  • Fukuda A, Kano S, Nakamaru Y, Morita S, Hoshino K, Fujiwara K, Homma A.:Notch Signaling in Acquired Middle Ear Cholesteatoma.

    Otol Neurotol. 42 :e1389-e1395, 2021

  • Yokokawa T, Ariizumi Y, Hiramatsu M, Kato Y, Endo K, Obata K, Kawashima K, Sakata T, Hirano S, Nakashima T, Sekine T, Kiyuna A, Uemura S, Okubo K, Sugimoto T, Tateya I, Fujimoto Y, Horii A, Kimura Y, Hyodo M, Homma A:Management of tracheostomy in COVID-19 patients: The Japanese experience.

    Auris Nasus Larynx. 48:525-529,2021

  • Yokokawa T, Homma A:Authors’ reply to: Comment on the article by Dr. Dmitry Tretiakow: Management of tracheostomy in COVID-19 patients: The Japanese experience.

    Auris Nasus Larynx. 48:802,2021

  • Fujima N, Andreu-Arasa VC, Meibom SK, Mercier GA, Truong MT, Hirata K, Yasuda K, Kano S, Homma A, Kudo K, Sakai:Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.

    BMC Cancer 21(1):900, 2021

  • Fujima N, Shimizu Y, Yoshida D, Kano S, Mizumachi T, Homma A, Yasuda K, Onimaru R, Sakai O, Kudo K, Shirato H.: Multiparametric Analysis of Tumor Morphological and Functional MR Parameters Potentially Predicts Local Failure in Pharynx Squamous Cell Carcinoma Patients.

    J Med Invest. 68: 354-361, 2021

  • Kariya S, Shimizu Y, Hanai N, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Fujiwara A, Yamada T, Homma A:Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting.

    Int J Clin Oncol. 26:1049-1056,2021

  • Hanai N, Shimizu Y, Kariya S, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Sakurai D, Asakage T, Doi I, Yamada T, Homma A:Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study.

    Int J Clin Oncol. 26:494-506,2021

  • Hanai N, Shimizu Y, Kariya S, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Sakurai D, Asakage T, Doi I, Yamada T, Homma A:Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicentre retrospective clinical study.

    Int J Clin Oncol. 26:1005-1006,2021

次ページへ » もっと見る